NWPF

News ArchivesRead News

Eye implants offer Parkinson’s hope

Thursday December 15, 2005

Wai Lang Chu

12/13/05(Archives of Neurology) - A new therapy for Parkinson’s disease involving brain implants has been developed by US scientists, who believe this new treatment is a viable alternative to drugs currently used to treat this chronic irreversible brain condition.

Levodopa is currently the most common drug treatment for the brain condition but the pills can leave people susceptible to involuntary movements such as twitches. It is normally prescribed a few years after diagnosis as the symptoms get worse.

In addition, disease progression and long-term oral treatment with levodopa may lead to the development of motor fluctuations and dyskinesias

This new approach involved taking levadopa producing eye cells taken from a dead donor and implanting the directly into the brains of six Parkinsons patients. The researchers reported no serious side effects.

Eye cells that form retinal pigment epithelial tissue produce levodopa and can be isolated from human eye tissue and implanted in the brain. Research on animals has shown that the cell implants can help treat the symptoms safely.

The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinson’s, said researcher Natividad Stover of the University of Alabama.

One year later, the patients scored 48 per cent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the report.

"The implants were well tolerated," the report said. "Improvement was also observed in activities of daily living (and) quality of life."

The study is additional proof that the technique could work on humans and paves the way for a larger, more thorough study.

Indeed, Stover added that a randomised, double-blind, placebo-controlled study was now in the pipeline to test the treatment further.

For most patients, the levodopa pills lose their effectiveness over five years or less, and larger and larger doses are needed to keep at bay the involuntary movements and shaking symptomatic of the disease.

Some scientists have viewed implanting foetal stem cells into the brains of Parkinson’s patients as a promising avenue to restoring dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.

Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy

Recent News

Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis